Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

Sam Chun Dang Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	105,585	40,427	22,101	49,113	58,935
Short-Term Investments	35,305	41,006	43,960	42,048	42,194
Trading Asset Securities	1,027	11,311	20,188	10,863	836.67
Cash & Short-Term Investments	141,917	92,744	86,248	102,025	101,966
Cash Growth	53.02%	7.53%	-15.46%	0.06%	2.26%
Accounts Receivable	35,537	30,426	34,954	31,863	26,655
Other Receivables	22,977	4,644	3,494	2,698	5,290
Receivables	61,387	35,111	39,004	38,589	36,540
Inventory	38,191	35,263	31,913	27,908	25,336
Prepaid Expenses	687.39	451.24	113.26	137.53	95.87
Other Current Assets	350.36	337.11	470.48	260.25	2,589
Total Current Assets	242,532	163,906	157,749	168,920	166,528
Property, Plant & Equipment	103,595	90,009	87,212	74,112	63,276
Long-Term Investments	30,445	32,899	32,712	38,399	49,014
Goodwill	3,745	3,745	3,745	3,745	3,745
Other Intangible Assets	27,585	14,126	15,177	15,175	15,518
Long-Term Accounts Receivable	-0	-0	0	0	0
Long-Term Deferred Tax Assets	8,677	16,602	7,731	13,226	1,891
Long-Term Deferred Charges	90,856	78,429	61,918	27,461	13,607
Other Long-Term Assets	8,435	3,583	3,588	2,871	3,501
Total Assets	519,772	408,022	372,793	343,948	317,079
Accounts Payable	4,848	3,862	4,943	4,758	3,178
Accrued Expenses	15,688	11,428	10,865	8,328	6,448
Short-Term Debt	12,290	12,226	2,756	1,580	2,011
Current Portion of Long-Term Debt	16,000	20,000	-	20,000	-
Current Portion of Leases	1,536	1,470	1,330	713.57	914.89
Current Income Taxes Payable	21,226	1,298	576.79	1,098	1,093
Current Unearned Revenue	151.77	137.94	68.14	-	-
Other Current Liabilities	21,681	7,535	17,621	17,541	10,013
Total Current Liabilities	93,421	57,957	38,160	54,019	23,658
Long-Term Debt	17,000	16,000	67,822	26,060	20,000
Long-Term Leases	3,115	3,929	4,683	3,188	4,149
Long-Term Unearned Revenue	44,610	19,208	7,418	-	-
Other Long-Term Liabilities	824.08	152.9	147.25	66.35	0
Total Liabilities	170,368	109,562	127,151	93,647	59,383
Common Stock	11,729	11,729	11,384	11,384	11,384
Additional Paid-In Capital	158,174	102,853	50,496	50,124	50,124
Retained Earnings	95,452	106,015	112,079	112,514	126,987
Treasury Stock	-568.09	-1,988	-1,988	-1,988	-1,988
Comprehensive Income & Other	1,319	1,889	1,771	2,060	118.66
Total Common Equity	266,105	220,499	173,741	174,095	186,626
Minority Interest	83,299	77,961	71,901	76,206	71,070
Shareholders' Equity	349,404	298,460	245,642	250,301	257,696
Total Liabilities & Equity	519,772	408,022	372,793	343,948	317,079
Total Debt	49,941	53,625	76,590	51,541	27,075
Net Cash (Debt)	91,975	39,119	9,658	50,484	74,891
Net Cash Growth	135.12%	305.04%	-80.87%	-32.59%	-1.27%
Net Cash Per Share	3993.76	1744.45	437.65	2287.64	3456.67
Filing Date Shares Outstanding	23.26	22.76	22.07	22.07	22.07
Total Common Shares Outstanding	23.26	22.76	22.07	22.07	22.07
Working Capital	149,112	105,949	119,590	114,901	142,869
Book Value Per Share	11441.71	9689.07	7872.97	7889.00	8456.84
Tangible Book Value	234,775	202,627	154,819	155,175	167,363
Tangible Book Value Per Share	10094.60	8903.78	7015.53	7031.64	7583.95
Land	16,224	16,224	15,423	15,529	15,529
Buildings	53,155	50,909	50,664	46,430	43,052
Machinery	71,494	59,829	56,280	43,220	40,867
Construction In Progress	26,187	19,473	13,800	14,923	4,597

Source: S&P Global Market Intelligence. Standard template. Financial Sources.